Characterization of novel nitazene recreational drugs: Insights into their risk potential from in vitro µ-opioid receptor assays and in vivo behavioral studies in mice.

Autor: Vandeputte MM; Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium. Electronic address: marthe.vandeputte@ugent.be., Glatfelter GC; Designer Drug Research Unit (DDRU), Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA. Electronic address: grant.glatfelter@nih.gov., Walther D; Designer Drug Research Unit (DDRU), Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA. Electronic address: dwalther@intra.nida.nih.gov., Layle NK; Forensic Chemistry Division, Cayman Chemical Company, Ann Arbor, MI 48108, USA. Electronic address: nlayle@caymanchem.com., St Germaine DM; Forensic Chemistry Division, Cayman Chemical Company, Ann Arbor, MI 48108, USA. Electronic address: dstgermaine@caymanchem.com., Ujváry I; iKem BT, Budapest H-1033, Hungary. Electronic address: ujvary@iif.hu., Iula DM; Forensic Chemistry Division, Cayman Chemical Company, Ann Arbor, MI 48108, USA. Electronic address: diula@caymanchem.com., Baumann MH; Designer Drug Research Unit (DDRU), Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA. Electronic address: mbaumann@intra.nida.nih.gov., Stove CP; Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium. Electronic address: christophe.stove@ugent.be.

Publikováno v: Pharmacological research [Pharmacol Res] 2024 Dec; Vol. 210, pp. 107503. Date of Electronic Publication: 2024 Nov 07.